NEO-CYT is a randomized, multi-centre trial of neoadjuvant MDNA11 (before curative intent surgery) sponsored by the Fondazione Melanoma Onlus, and led by Professor Paolo A. Ascierto of the Istituto ...

Hover Energy’s CEO and Founder, Christopher Griffin, outlines how award-winning microgrid design, artificial intelligence (AI ...

Key Takeaways OMB has issued a guidance memorandum to streamline the review of deregulatory actions. OMB will accelerate ...

Contraception and family planning are vital aspects of sexual and reproductive health and rights. Despite major advances in ...

November 4, 2025 • Reporters from the NPR Network are covering the uncertainty and lapse in benefits in states across the country. November 3, 2025 • About 1 in 8 U.S. residents get an average of $187 ...

Vedanta is the top bidder for Jaiprakash Associates' power assets. This acquisition aligns with Vedanta's goal to significantly increase its power production capacity in India. While other entities ...